Flagship Harbor Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-700
Closed -$26K 729
2020
Q3
$26K Hold
700
﹤0.01% 1051
2020
Q2
$24K Hold
700
﹤0.01% 1081
2020
Q1
$15K Hold
700
﹤0.01% 1109
2019
Q4
$15K Hold
700
﹤0.01% 1192
2019
Q3
$15K Buy
700
+300
+75% +$8.31K ﹤0.01% 1171
2019
Q2
$14K Hold
400
﹤0.01% 1177
2019
Q1
$12K Buy
+400
New +$11.7K ﹤0.01% 1223

Other funds holding CDNA

Flagship Harbor Advisors's CDNA Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of CareDx (CDNA) in Q4 2020, closing a stake of 700 shares — an estimated $26K sold.

Flagship Harbor Advisors first reported a position in CDNA in Q1 2019 and held it in 7 quarters. The position peaked at $26K in Q3 2020. 233 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining CareDx position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 700 CareDx shares in Q4 2020, an estimated $26K.
  • Flagship Harbor Advisors first reported a position in CareDx in Q1 2019 and held it in 7 quarters.
  • Flagship Harbor Advisors's CareDx position peaked at $26K in Q3 2020.
  • 233 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.